Trimetazidine – Cardiology MCQ
Trimetazidine is an antianginal agent which acts by inhibition of:
A. Beta oxidation of fatty acids
B. Anaerobic metabolism of glucose
C. Calcium channels
D. Beta adrenergic receptors
Please check the YouTube video above for discussion
Related Posts
-
D-dimer and thromboembolism – Cardiology MCQ
No Comments | Jun 4, 2015 -
Statin adverse effect – Cardiology MCQ – Answer
No Comments | Jul 2, 2018 -
Doubling dose of statin – Cardiology MCQ
No Comments | Oct 31, 2013 -
Echocardiographic view – Cardiology MCQ
No Comments | Feb 2, 2011
About The Author
Johnson Francis
Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal